Physician profile
Michael J Barrett
NPI 1760473235
$2,480.47
in general payments reported to CMS, 2019-2025
28 companies · $186 in 2025
The $186 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2020: $175 · 2021: $310 · 2022: $653 · 2023: $384 · 2024: $520 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,091.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,090.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $474.06 | 2019-2024 | N/A, Futura Csi, Citrefix |
| Smith+Nephew, INC. | $268.58 | 2021-2023 | Q-Fix, Grafix Pl, Evos |
| Organogenesis INC. | $268.35 | 2021-2023 | Puraply |
| Kerecis Limited | $187.51 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Bioventus LLC | $177.13 | 2019-2021 | |
| Biotissue Holdings INC. | $135.44 | 2022-2023 | |
| Abbvie INC. | $134.51 | 2022-2024 | Dalvance |
| Sandoz INC. | $112.32 | 2019-2020 | |
| Arthrex, INC. | $88.45 | 2022 | |
| Treace Medical Concepts, INC. | $81.30 | 2023-2024 | |
| Sanara Medtech INC. | $66.50 | 2022 | |
| Sebela Pharmaceuticals INC. | $64.35 | 2019 | |
| Triad Life Sciences INC. | $64.11 | 2022 | |
| Abbott Laboratories | $50.81 | 2021-2022 | |
| Horizon Therapeutics Plc | $44.27 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anika Therapeutics, INC. | $30.83 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $29.67 | 2021 | |
| Nvision Biomedical Technologies, INC. | $29.30 | 2022 | |
| Arthrosurface Incorporated | $26.16 | 2019 | |
| Medtronic, INC. | $25.78 | 2022 | |
| Mission Medical Distribution, LLC | $22.14 | 2025 | |
| Davol INC. | $18.09 | 2022 | |
| Paratek Pharmaceuticals, INC. | $16.53 | 2022 | |
| Amgen INC. | $14.66 | 2024 | Krystexxa |
| Journey Medical Corporation | $14.51 | 2021 | |
| Medline Industries LP | $14.04 | 2019 | |
| Pfizer INC. | $11.67 | 2019 | |
| In2bones USA, LLC | $9.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Barrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.